<IMS-DOCUMENT>0000830158-94-000017.txt : 19950106
<IMS-HEADER>0000830158-94-000017.hdr.sgml : 19950106
ACCESSION NUMBER:		0000830158-94-000017
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	19941230
ITEM INFORMATION:		Other events
FILED AS OF DATE:		19941230
SROS:			NASD

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SEAFIELD CAPITAL CORP
		CENTRAL INDEX KEY:			0000830158
		STANDARD INDUSTRIAL CLASSIFICATION:	8071
		IRS NUMBER:				431039532
		STATE OF INCORPORATION:			MO
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16946
		FILM NUMBER:		94567167

	BUSINESS ADDRESS:	
		STREET 1:		2600 GRAND AVE STE 500
		STREET 2:		P O BOX 410949
		CITY:			KANSAS CITY
		STATE:			MO
		ZIP:			64141
		BUSINESS PHONE:		8168427000

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 410949
		STREET 2:		2600 GRAND AVENUE, SUITE 500
		CITY:			KANSAS CITY
		STATE:			MO
		ZIP:			64141

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BMA CORP /MO/
		DATE OF NAME CHANGE:	19910520

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SEAFIELD CAPTIAL CORP
		DATE OF NAME CHANGE:	19910520

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BMA PROPERTIES INC
		DATE OF NAME CHANGE:	19880411
</IMS-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<TEXT>
SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report: December 30, 1994

Seafield Capital Corporation 
------------------------------------------------------
(Exact name of registrant as specified in its charter)

Missouri 0-16946 43-1039532
-----------------------------------------------------------------
(State of other (Commission File Number) (IRS Employer
jurisdiction of Identification
incorporation) Number)

2600 Grand Ave. Suite 500
P. O. Box 410949
Kansas City, MO 64141
-----------------------------------------------------------------
(Address of principal executive offices) (Zip code)

(816) 842-7000 
-----------------------------------------------------------------
(Registrant's telephone number, including area code)

Item 5. Other Events

On December 23, 1994, Seafield Capital Corporation (Seafield) issued a news 
release. The text of the news release is as follows:

Seafield Capital Corporation (Seafield) announced today that LabOne, Inc. 
(LabOne), Seafield's 82% owned subsidiary, was notified today by Epitope that
the Food and Drug Administration (FDA) had approved its OraSure (registered 
trademark) oral specimen collection device for use in detecting antibodies 
against the HIV-1 virus.

Bert Hood, chairman, president and chief executive officer of LabOne, said, 
"LabOne plans to begin marketing OraSure (registered trademark) in the near 
future. The financial impact for LabOne cannot be determined at this time."

LabOne operates a centralized laboratory in the Kansas City area which markets
clinical, substance abuse and insurance laboratory testing services nationwide.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this report to be signed on its behalf by the 
undersigned hereunto duly authorized officer.

Seafield Capital Corporation

Date: December 30, 1994 By: /s/ Steven K. Fitzwater
-------------------------------------
Steven K. Fitzwater
Vice President, Chief Accounting
Officer and Secretary
</TEXT>
</DOCUMENT>
</IMS-DOCUMENT>